PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy 01-05-2016 - 30-04-2022 Show more information EU-Programme-Call Horizon 2020 H2020-EU.2. INDUSTRIAL LEADERSHIP H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies H2020-EU.2.1.2.0. INDUSTRIAL LEADERSHIP - Nanotechnologies - Cross-cutting call topics H2020-NMP-2015-two-stage NMP-11-2015 Nanomedicine therapy for cancer
NoCanTher | Nanomedicine upscaling for early clinical phases of multimodal cancer therapy 01-04-2016 - 30-09-2021 Show more information EU-Programme-Call Horizon 2020 H2020-EU.2. INDUSTRIAL LEADERSHIP H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies H2020-EU.2.1.2. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies H2020-EU.2.1.2.0. INDUSTRIAL LEADERSHIP - Nanotechnologies - Cross-cutting call topics H2020-NMP-2015-two-stage NMP-11-2015 Nanomedicine therapy for cancer